- Tweeter
republish
In France, twenty-six professors and doctors are alarmed, in a tribune published by the Journal du Dimanche , shortages of more and more frequent drugs. 868 ruptures or tensions were reported last year, which is 20 times more than in 2008. They therefore call for immediate reforms.
These shortages affect essential drugs: antibiotics, vaccines, corticosteroids, cancer treatments or cardiac diseases. Often falling into the public domain, these drugs now less report to the pharmaceutical companies that manufacture them.
To reduce their costs, 80% of these treatments are now manufactured outside the European Union, mainly in Asia. But on-site demand has grown in recent years, as countries like China have emerged, blowing up demand.
Medication sold at a tense flow
Today, medicines are produced and sold at just-in-time, resulting in more frequent shortages in Europe because they are located farther away from production areas.
In their gallery, professors and doctors ask the laboratories to build stocks, which they are reluctant to do so far, because storing drugs is expensive.
The doctors also ask to relocate the production in Europe evoking an impact of only a few cents on the price of medicine sales. In September, a working group to find solutions to these growing drug shortages will be set up in France.
Increasingly frequent in pharmacy and hospital, breaks in the supply of drugs endanger the lives of patients. https://t.co/iOTnXiZksJ
The JDD (@leJDD) August 18, 2019